POSA243 Approaches to Immune Checkpoint Inhibitor (ICI) First-Line Maintenance Therapy (1L-MT) in Unresectable Locally Advanced (LA) or Metastatic Urothelial Cancer (mUC) in France, Germany, Italy, Spain, and the UK (EU5)
Abstract
Authors
N Milloy M Berry M Kostikas S Li M Kearney M Bharmal N Costa J Chang